List of Studies ( Metabolite:Ethosuximide)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST002405 | AN003919 | Stool global metabolite levels in peanut allergy (Part 2) | Feces | Human | Peanut allergy | Icahn School of Medicine at Mount Sinai | Absolute Intensity |
ST002761 | AN004487 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
ST001671 | AN002728 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism | Bacterial cells | Bacteria | Stanford University | counts (area) | |
ST001688 | AN002757 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism (part-II) | Bacterial cells | Bacteria | Stanford University | counts (area) | |
ST001324 | AN002203 | Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress | Pacific Abalone | Institute of Oceanology, Chinese Academy of Sciences | mV*s | ||
ST000291 | AN000464 | LC-MS Based Approaches to Investigate Metabolomic Differences in the Urine of Young Women after Drinking Cranberry Juice or Apple Juice | Urine | Human | University of Florida | Peak area | |
ST000292 | AN000466 | LC-MS Based Approaches to Investigate Metabolomic Differences in the Plasma of Young Women after Drinking Cranberry Juice or Apple Juice | Blood | Human | University of Florida | Peak area | |
ST000286 | AN000454 | Mouse skeletal myotube chronic low-frequency stimulation | Myotubes | Mouse | University of Florida | Peak height | |
ST000421 | AN000663 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000422 | AN000667 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST001683 | AN002747 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Blood | Mouse | Stanford University | Raw ion count (peak area) | |
ST001683 | AN002747 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Feces | Mouse | Stanford University | Raw ion count (peak area) | |
ST001683 | AN002747 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Intestine | Mouse | Stanford University | Raw ion count (peak area) | |
ST001683 | AN002747 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Urine | Mouse | Stanford University | Raw ion count (peak area) | |
ST000045 | AN000072 | Plasma metabolomics: Comparison of non-diabetic controls with T1D patients | Blood | Human | Mayo Clinic | Raw MS Intensities | |
ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
ST000047 | AN000080 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |